Abstract

Chronic immunosuppressive therapy is critical to all transplant patients to help prevent rejection, chronic injury and loss of allograft. Tacrolimus is used as immunosuppression in more than ninety percent of kidney transplant recipients, and requires drug level monitoring. It is known that many prescribed medications can alter tacrolimus metabolism and lead to unpredictable levels that may expose patients to the above-mentioned complications. However, the use of over-the-counter medications is often overlooked. Here, we present a case report in which over-the-counter calcium carbonate significantly affected the patient's tacrolimus metabolism leading to unpredictable levels.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.